• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Eye treatment company Avedro lands $25 million | Funding Roundup

Eye treatment company Avedro lands $25 million | Funding Roundup

July 8, 2011 By MassDevice staff

Funding

Avedro Inc. landed $25 million in a series C financing round, company officials announced yesterday.

The Waltham, Mass.-based company will use the funds to expand its commercial operations overseas.

Avedro, a private company, also plans to pursue U.S. Food and Drug Administration clearance for its Vedera cornea flattening treatment, designed to treat near-sightedness, and its KXL corneal cross-linking system.

The KXL system won CE Mark approval in the European Union in November 2010.

Check out the MassDevice podcast with Avedro Inc. CEO David Muller from December 2010.

Funding was led by SCP Vitalife and followed by Aperture Venture Partners who joined by existing investors Prism VentureWorks, De Novo Ventures, Flagship Ventures, Borealis Ventures and Echelon Ventures, according to the release.

As part of the round Jeff Dykan of SCP Vitalife will join Avedro’s board of directors, and Eric Sillman of Aperture Venture Partners comes on as a board observer.

Here’s a roundup of other dealflow and investment news:

  • Cardiovascular Systems announced $3.5 million loan agreement
    Cardiovascular Systems Inc. (NSDQ:CSII) announced that it issued a senior convertible promissory to the tune of $3.5 million to Partners for Growth III in exchange for a loan of the same amount pursuant to an agreement made between the companies in April 2010.
    Read more

  • Optical biopsy company closes $2.5 million funding round
    Precision Biopsy, a Boston-based cancer diagnostics company, announced the official close of a $2.5 million round. The funds will go toward product development and preparation market introduction.
    Read more
  • SpineVision touts $5 million
    SpineVision announced that it raised $5 million, which will go primarily toward acceleration market penetration of the Paris-based company’s minimally invasive motion-preservation spinal therapies.

    "We now have a focused and streamlined international operation that is steadfastly penetrating the market," said Gérard Hascoët, chairman & CEO of SpineVision.
    Read more

  • CareFusion lands $550 million credit facility
    CareFusion Corp. (NYSE:CFN) arranged a $550 million unsecured revolving credit facility with JPMorgan Chase Bank this week. The credit has a five-year term and allows the San Diego-based company to request up to $200 million more under certain conditions.
    Read more

Filed Under: Funding Roundup, News Well, Optical/Ophthalmic Tagged With: Avedro Inc., Cardiovascular Systems Inc., CareFusion Corp., Precision Biopsy, SpineVision

More recent news

  • GT Medical raises $53M to support brain tumor treatment
  • Imperative Care, Proximie partner to develop surgical robot to treat stroke
  • Carlsmed launches IPO roadshow
  • Varian introduces IntelliBlate for image-guided cancer therapy in Europe
  • Henry Schein CEO Stanley M. Bergman to retire

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy